Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial

BACKGROUND: The optimal protocol for (125)I-transperineal prostatic brachytherapy (TPPB) in intermediate-risk prostate cancer (PCa) patients remains controversial. Data on the efficacy of combining androgen-deprivation therapy (ADT) with (125)I-TPPB in this group remain limited and consequently the...

Descripción completa

Detalles Bibliográficos
Autores principales: Miki, Kenta, Kiba, Takayoshi, Sasaki, Hiroshi, Kido, Masahito, Aoki, Manabu, Takahashi, Hiroyuki, Miyakoda, Keiko, Dokiya, Takushi, Yamanaka, Hidetoshi, Fukushima, Masanori, Egawa, Shin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984426/
https://www.ncbi.nlm.nih.gov/pubmed/20964826
http://dx.doi.org/10.1186/1471-2407-10-572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984426/
https://www.ncbi.nlm.nih.gov/pubmed/20964826
http://dx.doi.org/10.1186/1471-2407-10-572

Ejemplares similares